Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switching to Tenofovir Disoproxil in Chronic Hepatitis B
NCT03485534Phase 4Completed
- Sponsor
- Daewoong Pharmaceutical
- Start
- Jan 2018
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tenofovir disoproxil fumarate in Chronic Hepatitis B (CHB), sponsored by Daewoong Pharmaceutical. Started Jan 2018; status: completed.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT03485534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03485534.